Published in Mol Biochem Parasitol on July 01, 1986
Active isoprenoid pathway in the intra-erythrocytic stages of Plasmodium falciparum: presence of dolichols of 11 and 12 isoprene units. Biochem J (1999) 1.22
Terpenes arrest parasite development and inhibit biosynthesis of isoprenoids in Plasmodium falciparum. Antimicrob Agents Chemother (2004) 1.15
Non-detergent sulphobetaines: a new class of mild solubilization agents for protein purification. Biochem J (1995) 1.10
Limonene arrests parasite development and inhibits isoprenylation of proteins in Plasmodium falciparum. Antimicrob Agents Chemother (2001) 0.99
Plasmodium chabaudi p68 serine protease activity required for merozoite entry into mouse erythrocytes. Proc Natl Acad Sci U S A (1992) 0.97
Identification, molecular cloning and functional characterization of an octaprenyl pyrophosphate synthase in intra-erythrocytic stages of Plasmodium falciparum. Biochem J (2005) 0.94
Intraerythrocytic stages of Plasmodium falciparum biosynthesize menaquinone. FEBS Lett (2010) 0.86
In vitro and in vivo antiplasmodial activities of risedronate and its interference with protein prenylation in Plasmodium falciparum. Antimicrob Agents Chemother (2011) 0.86
A Plasmodium falciparum gene encoding a heat shock-like antigen related to the rat 78 Kd glucose-regulated protein. Nucleic Acids Res (1988) 0.83
In vivo antimalarial activity and mechanisms of action of 4-nerolidylcatechol derivatives. Antimicrob Agents Chemother (2015) 0.75
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet (2000) 5.49
Epidemiological basis for clinical diagnosis of childhood malaria in endemic zone in West Africa. Lancet (1991) 5.11
New controlling element in the Lac operon of E. coli. Nature (1968) 4.63
Mutational alteration of the maximal level of Lac operon expression. Cold Spring Harb Symp Quant Biol (1966) 3.71
Transmission of antiretroviral-drug-resistant HIV-1 variants. Lancet (1999) 3.43
Genetics and physiology of defective lysogeny in K12 (lambda): studies of early mutants. Virology (1966) 3.39
Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. Nat Biotechnol (1998) 3.28
Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen. J Exp Med (1998) 3.24
Regulation of repressor expression in lambda. Proc Natl Acad Sci U S A (1970) 3.12
Structure of the malB region in Escherichia coli K12. I. Genetic map of the malK-lamB operon. Mol Gen Genet (1979) 2.99
lamB mutations in E. coli K12: growth of lambda host range mutants and effect of nonsense suppressors. Mol Gen Genet (1976) 2.85
F-prime factor formation in E. coli K12. Genet Res (1966) 2.80
Major surface antigen gene of a human malaria parasite cloned and expressed in bacteria. Nature (1984) 2.74
Identification of phosphatidylinositol-specific phospholipase C activity in Listeria monocytogenes: a novel type of virulence factor? Mol Microbiol (1991) 2.68
[On the early regulation of the lambda bacteriophage]. C R Acad Sci Hebd Seances Acad Sci D (1968) 2.52
Acute HIV infection: impact on the spread of HIV and transmission of drug resistance. AIDS (2001) 2.42
Episomes. Annu Rev Microbiol (1967) 2.36
The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. Proc Natl Acad Sci U S A (1997) 2.24
Identification of a single promoter in E. coli for rplJ, rplL and rpoBC. Nature (1978) 2.22
Dietetic guidelines on food and nutrition in the secondary prevention of cardiovascular disease - evidence from systematic reviews of randomized controlled trials (second update, January 2006). J Hum Nutr Diet (2006) 2.09
Antigens of the erythrocytes stages of the human malaria parasite Plasmodium falciparum detected by monoclonal antibodies. Mol Biochem Parasitol (1983) 2.00
Nosocomial outbreak of multiple bloodborne viral infections. J Infect Dis (2001) 1.89
Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial. AIDS (2003) 1.76
Evidence for a lambda transducing phage carrying the genes for the beta and beta' subunits of Escherichia coli RNA polymerase. Mol Gen Genet (1974) 1.75
Polymorphism of the precursor for the major surface antigens of Plasmodium falciparum merozoites: studies at the genetic level. EMBO J (1985) 1.69
A new method for selecting RNA polymerase mutants. J Mol Biol (1970) 1.68
The regulation and mechanism of DNA synthesis in bacteriophage lambda. Cold Spring Harb Symp Quant Biol (1968) 1.67
Rapid and sensitive detection of enteroviruses in specimens from patients with aseptic meningitis. J Clin Microbiol (1996) 1.67
Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in seroconvertors infected with zidovudine-resistant variants. J Virol (1998) 1.65
Detection of low HIV-1 RNA levels in plasma. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.65
In vivo and in vitro functional alterations of the bacteriophage lambda receptor in lamB missense mutants of Escherichia coli K-12. J Bacteriol (1981) 1.65
Emergence delirium in a child given oral midazolam for conscious sedation. Ann Emerg Med (1994) 1.63
Characterisation of a repetitive DNA sequence from the malaria parasite, Plasmodium falciparum. Mol Biochem Parasitol (1986) 1.61
Human antisera detect a Plasmodium falciparum genomic clone encoding a nonapeptide repeat. Nature (1984) 1.51
Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis (1990) 1.50
A malaria protein exported into a new compartment within the host erythrocyte. EMBO J (1987) 1.49
Explanations accounting for transduction by bacteriophage lambda in maltose negative bacteriophage lambda resistant mutants of Escherichia coli K-12. Mol Gen Genet (1978) 1.48
Analysis of membrane proteins by two-dimensional electrophoresis: comparison of the proteins extracted from normal or Plasmodium falciparum-infected erythrocyte ghosts. Electrophoresis (1999) 1.47
Infection of primary human microglia and monocyte-derived macrophages with human immunodeficiency virus type 1 isolates: evidence of differential tropism. J Virol (1996) 1.47
Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995. AIDS (1998) 1.46
The complete sequence of a Plasmodium malariae SSUrRNA gene and its comparison to other plasmodial SSUrRNA genes. Mol Biochem Parasitol (1991) 1.44
Decay of cell-associated HIV-1 DNA correlates with residual replication in patients treated during acute HIV-1 infection. AIDS (2000) 1.44
The dental management of patients with natural rubber latex allergy. Br Dent J (1998) 1.44
Impact of drug resistance mutations on virologic response to salvage therapy. Swiss HIV Cohort Study. AIDS (1999) 1.44
[Post-exposure HIV prevention: eligibility of patients recently infected by sexual exposure]. Schweiz Med Wochenschr (1999) 1.40
Sexual transmission during the incubation period of primary HIV infection. JAMA (2001) 1.37
Differential effects of omeprazole and pantoprazole on the pharmacodynamics and pharmacokinetics of clopidogrel in healthy subjects: randomized, placebo-controlled, crossover comparison studies. Clin Pharmacol Ther (2010) 1.36
Ignition and explosion risks of nanopowders. J Hazard Mater (2010) 1.34
Loss of antibodies against hepatitis C virus in HIV-seropositive intravenous drug users. AIDS (1990) 1.33
Species- and stage-specific antigens in exoerythrocytic stages of Plasmodium falciparum. Am J Trop Med Hyg (1984) 1.30
Updated European recommendations for the clinical use of HIV drug resistance testing. Antivir Ther (2004) 1.28
The diagnosis of malaria infection using a solid-phase radioimmunoassay for the detection of malaria antigens. Application to the detection of Plasmodium berghei infection in mice. Parasitology (1980) 1.28
Protective immunization of the squirrel monkey against asexual blood stages of Plasmodium falciparum by use of parasite protein fractions. Proc Natl Acad Sci U S A (1984) 1.28
Resistance to nucleoside analog reverse transcriptase inhibitors mediated by human immunodeficiency virus type 1 p6 protein. J Virol (2001) 1.22
Epitopes recognized by human T cells map within the conserved part of the GP190 of P. falciparum. Science (1988) 1.19
Plasmodium falciparum subtilisin-like protease 2, a merozoite candidate for the merozoite surface protein 1-42 maturase. Proc Natl Acad Sci U S A (1999) 1.19
Severity and prognosis of acute human immunodeficiency virus type 1 illness: a dose-response relationship. Clin Infect Dis (1998) 1.18
Plaque antibody selection: rapid immunological analysis of a large number of recombinant phage clones positive to sera raised against Plasmodium falciparum antigens. J Immunol Methods (1986) 1.18
Double-blind randomized evaluation of clinical and biological tolerance of polyethylene glycol 4000 versus lactulose in constipated children. J Pediatr Gastroenterol Nutr (2005) 1.18
Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues. Antimicrob Agents Chemother (2000) 1.18
The gene for an exported antigen of the malaria parasite Plasmodium falciparum cloned and expressed in Escherichia coli. Nucleic Acids Res (1985) 1.18
High frequency of non-B subtypes in newly diagnosed HIV-1 infections in Switzerland. J Acquir Immune Defic Syndr (1999) 1.17
Isotypic pattern of the polyclonal B cell response during primary infection by Plasmodium chabaudi and in immune-protected mice. Eur J Immunol (1987) 1.15
Expression of human beta-hexosaminidase alpha-subunit gene (the gene defect of Tay-Sachs disease) in mouse brains upon engraftment of transduced progenitor cells. Nat Med (1996) 1.15
Response of HIV RNA to didanosine as a predictive marker of survival. AIDS (1995) 1.15
Cell-associated HIV-1 RNA in blood as indicator of virus load in lymph nodes. The Swiss HIV Cohort Study. J Infect Dis (1999) 1.14
Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome. Medicine (Baltimore) (1992) 1.11
Time of initiation of antiretroviral therapy: impact on HIV-1 viraemia. The Swiss HIV Cohort Study. AIDS (2000) 1.10
Non-detergent sulphobetaines: a new class of mild solubilization agents for protein purification. Biochem J (1995) 1.10
Hepatitis C: a possible etiology for cryoglobulinaemia type II. Clin Exp Immunol (1992) 1.07
Identification of a family of Rab G-proteins in Plasmodium falciparum and a detailed characterisation of pfrab6. Mol Biochem Parasitol (1996) 1.06
Protective antibodies against erythrocytic stages of Plasmodium falciparum in experimental infection of the squirrel monkey, Saimiri sciureus. Parasite Immunol (1982) 1.06
General method for fine mapping of the Escherichia coli K-12 lamB gene: localization of missense mutations affecting bacteriophage lambda adsorption. J Bacteriol (1981) 1.06
The Drosophila teashirt homeotic protein is a DNA-binding protein and modulo, a HOM-C regulated modifier of variegation, is a likely candidate for being a direct target gene. Mech Dev (1996) 1.05
Detection of human immunodeficiency virus type 1 (HIV-1) RNA in pools of sera negative for antibodies to HIV-1 and HIV-2. J Clin Microbiol (1998) 1.05
Destruction of Leishmania mexicana amazonensis amastigotes within macrophages in culture by phenazine methosulfate and other electron carriers. J Exp Med (1982) 1.04
Chronic destructive lung disease associated with a novel mycobacterium. Am J Respir Crit Care Med (1994) 1.03
Mutations in SDCCAG8/NPHP10 Cause Bardet-Biedl Syndrome and Are Associated with Penetrant Renal Disease and Absent Polydactyly. Mol Syndromol (2011) 1.03
Prognostic value of viremia in patients with long-standing human immunodeficiency virus infection. Swiss HIV Cohort Study Group. J Infect Dis (1996) 1.02
Protein encapsulation within polyethylene glycol-coated nanospheres. I. Physicochemical characterization. J Biomed Mater Res (1998) 1.02
Growth-deficient mycobacteria in patients with AIDS: diagnosis by analysis of DNA amplified from blood or tissue. Clin Infect Dis (1995) 1.02
Incubation time of acute human immunodeficiency virus (HIV) infection and duration of acute HIV infection are independent prognostic factors of progression to AIDS. J Infect Dis (2000) 1.01
Peritoneal cytology: impact on disease-free survival in clinical stage I endometrioid adenocarcinoma of the uterus. Cancer Lett (2001) 0.99
Investigating theory of mind in schizophrenia: influence of verbalization in disorganized and non-disorganized patients. Schizophr Res (1999) 0.99
Genetic polymorphisms and the impact of a higher clopidogrel dose regimen on active metabolite exposure and antiplatelet response in healthy subjects. Clin Pharmacol Ther (2011) 0.98
Human T cell activation. Synergy between CD73 (ecto-5'-nucleotidase) and signals delivered through CD3 and CD2 molecules. J Immunol (1990) 0.98
Growth of secondary hair follicles of the Cashmere goat in vitro and their response to prolactin and melatonin. J Anat (1994) 0.97
[Early diagnosis of primary HIV infections: using a combined screening test (p24 antigen and anti-HIV antibodies)]. Schweiz Med Wochenschr (1999) 0.95
The Drosophila tumor suppressor gene lethal(2)giant larvae is required for the emission of the Decapentaplegic signal. Development (2001) 0.94
Comprehensive classification of symptoms and signs reported among 218 patients with acute HIV-1 infection. J Acquir Immune Defic Syndr (1999) 0.94
Behavioural changes in intravenous drug users in Geneva: rise and fall of HIV infection, 1980-1989. AIDS (1990) 0.94
Lambda transducing bacteriophage carrying deletions of the argCBH-rpoBC region of the Escherichia coli chromosome. J Bacteriol (1979) 0.93
Identification and expression in Escherichia coli of merozoite stage-specific genes of the human malarial parasite Plasmodium falciparum. Proc Natl Acad Sci U S A (1984) 0.93
V3 sequences in primary HIV-1 infection. AIDS (1995) 0.92
Epidemiology of vertically transmitted HIV-1 infection in Switzerland: results of a nationwide prospective study. Swiss Neonatal HIV Study Group. Eur J Pediatr (1992) 0.92
The S-antigen of Plasmodium falciparum Palo Alto represents a new S-antigen serotype. Mol Biochem Parasitol (1988) 0.91